InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Short-term Investments (2016 - 2026)

InflaRx (IFRX) posted Short-term Investments of $29.0 million for Q1 2026, down 18.02% sequentially from $35.4 million in Q4 2025, and up 11514.96% YoY from N/an in Q1 2025.

InflaRx (IFRX) Short-term Investments (2016 - 2026) Analysis & Trends

InflaRx has reported Short-term Investments for 11 years, with the latest figure at $29.0 million in Q1 2026.

  • Quarterly Short-term Investments rose 11514.96% year-over-year to $29.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.0 million (up 11514.96% YoY) and the FY2025 annual result came in at $34.4 million, down 7.81% from the prior year.
  • Short-term Investments declined to $29.0 million in Q1 2026 per IFRX's latest filing, from $35.4 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $56.0 million in Q1 2022 and troughed at $239668.8 in Q3 2022.
  • A 5-year average of $19.0 million and a median of $9.7 million in 2023 frame the typical range for Short-term Investments.
  • The sharpest annual moves came in 2022 and 2025: Short-term Investments sank 99.62% in 2022, then surged 15370.9% in 2025.
  • Over 5 years, Short-term Investments stood at $3.0 million in 2022, then jumped by 229.1% to $9.7 million in 2023, then surged by 278.09% to $36.8 million in 2024, then slipped by 3.8% to $35.4 million in 2025, then retreated by 18.02% to $29.0 million in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods registered $29.0 million, $35.4 million, and $44.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.04 Mn
Dec 31, 2025 35.43 Mn
Sep 30, 2025 44.65 Mn
Jun 30, 2025 39.61 Mn
Mar 31, 2025 250,044.50
Dec 31, 2024 36.83 Mn
Sep 30, 2024 34.80 Mn
Jun 30, 2024 256,035.41
Mar 31, 2024 2.71 Mn
Dec 31, 2023 9.74 Mn
Sep 30, 2023 258,609.91
Jun 30, 2023 20.64 Mn
Mar 31, 2023 8.55 Mn
Dec 31, 2022 2.96 Mn
Sep 30, 2022 239,668.82
Jun 30, 2022 253,332.06
Mar 31, 2022 56.03 Mn
Dec 31, 2021 31.12 Mn
Sep 30, 2021 -47.78 Mn
Jun 30, 2021 66.04 Mn